Inventor · disambiguated record
Joshua Ryan Dahlke
Also filed as: DAHLKE JOSHUA · DAHLKE JOSHUA RYAN
6 granted patents·9 pending applications·18 citations·filing 2019–2025
78Inventor score
Files withMIRATI THERAPEUTICS INC6PFIZER4ARRAY BIOPHARMA INC3COGENT BIOSCIENCES INC1GILEAD SCIENCES INC1
Top patents by PatentIndex Score
15 records- 0196US11453683B1KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·13 cites·84 claims
- 0292US11964989B2KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·2 cites·19 claims
- 0389US11802127B23,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitorsPFIZER·Filed 2022·Granted Oct 31, 2023·1 cites·53 claims
- 0488US11780835B2Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinasesARRAY BIOPHARMA INC·Filed 2021·Granted Oct 10, 2023·1 cites·9 claims
- 0584US11104676B2Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinasesARRAY BIOPHARMA INC·Filed 2019·Granted Aug 31, 2021·1 cites·4 claims
- 0678US2024174666A1PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASESARRAY BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0777US2024309020A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0876US11691973B23,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitorsPFIZER·Filed 2022·Granted Jul 4, 2023·0 cites·11 claims
- 0975US2024002384A13,4-dihydro-2,7-naphthyridine-1,6(2h,7h)-diones as mek inhibitorsPFIZER·Filed 2023·Application pending·0 cites
- 1071US2025263411A13,4-dihydro-2,7-naphthyridine-1,6(2h,7h)-diones as mek inhibitorsPFIZER·Filed 2025·Application pending·0 cites
- 1156US2024270741A1Compounds for fgfrs inhibitorsCOGENT BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1255US2023357277A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1354US2023339976A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1453US2023279025A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1543US2025296933A1Methods and intermediates for preparing therapeutic compoundsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →